BioMarin Pharma (BMRN) Tops Q1 EPS by 39c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $68.17 -1.67%
Financial Fact:
Royalty and license revenues: 1.63M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Royalty and license revenues: 1.63M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $0.60, $0.39 better than the analyst estimate of $0.21. Revenue for the quarter came in at $596.4 million versus the consensus estimate of $571.33 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $59 at H.C. Wainwright
- Navios Maritime Partners (NMM) Tops Q2 EPS by 34c
- China semiconductor equipment imports grow 9% in July, Barclays comments
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
